CompletedNot Applicable

Measurement of Serum Ferritin With a Cryo Detector Mass Spectrometer (CDMS)

Switzerland22 participantsStarted 2024-02-12

Plain-language summary

The study will explore the performance of the CDMS (Cryo Detector Mass Spectrometer) method in measuring SF (serum ferritin) in human serum of healthy individuals. This will be the first experience of testing SF with this method using biologic material of human origin.

Who can participate

Age range18 Years – 75 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * age 18-75 years * SF (serum ferritin) values known from a previous determination that must not be older than twelve months and not followed by a blood donation * fulfillment of the eligibility criteria for blood donation * negative serology for HBV (hepatitis B virus), HCV (hepatitis C virus), HIV (human immunodeficiency virus) as assessed in the context of a blood donation Exclusion Criteria: * acute illness * chronic inflammatory disease Since pregnancy is a contraindication for blood donation, no pregnant women will be included in the study.

What they're measuring

Assessment of the mass of serum ferritin molecules (kDa)

Timeframe: one time assessment at baseline

Trial details

NCT IDNCT05886309

SponsorUniversity Hospital, Basel, Switzerland

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-03-05

View on ClinicalTrials.gov More Serum Ferritin trials